Renaissance Technologies's ORGO Position Overview
Renaissance Technologies (via Renaissance Technologies LLC) currently holds 818,700 shares of Organogenesis Holdings Inc. (ORGO) worth $4.24 M, representing 0.01% of the portfolio. First purchased in 2019-Q4, this long-term strategic position has been held for 25 quarters.
Based on 13F filings, Renaissance Technologies has maintained a strategic position in ORGO, demonstrating sustained confidence in this investment. Largest addition occurred in Q3 2022, adding 710,800 shares. Largest reduction occurred in Q2 2023, reducing 542,298 shares.
Analysis based on 13F filings available since 2013 Q2
Renaissance Technologies's Organogenesis Holdings (ORGO) Holding Value Over Time
Track share changes against reported price movement
Quarterly Organogenesis Holdings (ORGO) Trades by Renaissance Technologies
| Report Date | Bought/Sold (Sh.) | % Change | Qtr. End Shares | Reported Price |
|---|---|---|---|---|
| Q4 2025 | -2,800 | Reduce 0.34% | 818,700 | $5.18 |
| Q3 2025 | +17,600 | Add 2.19% | 821,500 | $4.22 |
| Q2 2025 | -239,600 | Reduce 22.96% | 803,900 | $3.66 |
| Q1 2025 | -30,000 | Reduce 2.79% | 1.04 M | $4.32 |
| Q4 2024 | +255,600 | Add 31.25% | 1.07 M | $3.20 |
| Q3 2024 | +22,200 | Add 2.79% | 817,900 | $2.86 |
| Q2 2024 | -11,400 | Reduce 1.41% | 795,700 | $2.80 |
| Q1 2024 | -50,625 | Reduce 5.90% | 807,100 | $2.84 |
| Q4 2023 | +173,631 | Add 25.38% | 857,725 | $4.09 |
| Q3 2023 | -22,008 | Reduce 3.12% | 684,094 | $3.18 |
| Q2 2023 | -542,298 | Reduce 43.44% | 706,102 | $0.00 |
| Q1 2023 | +75,002 | Add 6.39% | 1.25 M | $0.00 |
| Q4 2022 | -9,602 | Reduce 0.81% | 1.17 M | $0.00 |
| Q3 2022 | +710,800 | Add 150.53% | 1.18 M | $3.24 |
| Q2 2022 | +126,400 | Add 36.55% | 472,200 | $4.88 |
| Q1 2022 | +220,200 | Add 175.32% | 345,800 | $7.62 |
| Q4 2021 | -244,000 | Reduce 66.02% | 125,600 | $9.24 |
| Q3 2021 | -339,600 | Reduce 47.88% | 369,600 | $14.24 |
| Q2 2021 | +20,300 | Add 2.95% | 709,200 | $16.62 |
| Q1 2021 | +42,600 | Add 6.59% | 688,900 | $18.22 |
| Q4 2020 | +454,500 | Add 236.97% | 646,300 | $7.53 |
| Q3 2020 | +57,300 | Add 42.60% | 191,800 | $3.84 |
| Q2 2020 | +66,900 | Add 98.96% | 134,500 | $3.84 |
| Q1 2020 | +32,300 | Add 91.50% | 67,600 | $3.22 |
| Q4 2019 | +35,300 | New Buy | 35,300 | $4.82 |
Renaissance Technologies's Organogenesis Holdings Investment FAQs
Renaissance Technologies first purchased Organogenesis Holdings Inc. (ORGO) in Q4 2019, acquiring 35,300 shares, as reported in their 13F filing for that period. Note: Analysis reflects filings available since Q2 2013; earlier records may be incomplete.
Renaissance Technologies has held Organogenesis Holdings Inc. (ORGO) for 25 quarters since Q4 2019.
Renaissance Technologies's largest addition to Organogenesis Holdings Inc. (ORGO) was in Q3 2022, adding 1,183,000 shares worth $3.83 M.
According to the latest 13F filing for Q4 2025, Renaissance Technologies's firm, Renaissance Technologies LLC, owns 818,700 shares of Organogenesis Holdings Inc. (ORGO), valued at approximately $4.24 M.
As of the Q4 2025 filing, Organogenesis Holdings Inc. (ORGO) represents approximately 0.01% of Renaissance Technologies's publicly disclosed stock portfolio, making it one of their key holdings.
Renaissance Technologies's peak holding in Organogenesis Holdings Inc. (ORGO) was 1,248,400 shares, as reported at the end of Q1 2023.